Company / SG&A Expense
Vaxart, Inc. SG&A Expense History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$17.6M
FY2025
5-year range
$3.5M / $20.8M
FY2021-FY2025
Trend
-15.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 9 years, ranging from $3M in FY2017 to $21M in FY2024.
Based on SEC 10-K filings.
$18M in FY2025 with a 10-year CAGR of +6.5%.
Increased from $7M to $18M over the past 7 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +6.5%
Key checks
Key Insights
- In FY2025, sg&a expense decreased 15.3% year-over-year.
- Peak sg&a expense was recorded in FY2024.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.04 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.6M | -15.3% |
| FY2024 | $20.8M | +211.0% |
| FY2018 | $6.7M | +90.9% |
| FY2017 | $3.5M | -56.3% |
| FY2016 | $8.0M | -14.9% |
| FY2015 | $9.4M | -7.8% |
| FY2014 | $10.2M | -43.3% |
| FY2013 | $18.0M | +157.1% |
| FY2011 | $7.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026